Imovane

Zopiclone, the active ingredient in Imovane, is a cyclopyrrolone (non‑benzodiazepine hypnotic) presented as an oral tablet for oral use. It is prescribed to manage insomnia, helping adults who have difficulty initiating or maintaining sleep.

GNH USA supplies Imovane as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers.

Zopiclone is a cyclopyrrolone hypnotic used to treat sleep disorders.

Insomnia: facilitates falling asleep and reduces nighttime awakenings. Sleep onset insomnia: shortens the time required to fall asleep. Sleep maintenance insomnia: helps maintain sleep throughout the night.

Common Side Effects: - Drowsiness: feeling unusually sleepy during the day. - Dry mouth: reduced salivation leading to a dry sensation. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness or unsteadiness. - Bitter or unpleasant taste. - Nausea: feeling of stomach upset.

Serious or Rare Side Effects: - Complex sleep behaviours: sleepwalking, sleep‑driving, or other activities while not fully awake. - Allergic reactions: rash, itching, swelling, or difficulty breathing. - Mood changes: depression, anxiety, or suicidal thoughts. - Respiratory depression: slowed breathing, especially when combined with other depressants. - Dependence or withdrawal symptoms on abrupt discontinuation. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before prescribing Zopiclone, clinicians should consider several safety factors.

Assess renal function: adjust use in severe renal impairment. Avoid alcohol: concurrent use may increase sedation and respiratory depression. Limit duration: recommended for short‑term use only, typically up to 2–4 weeks. Monitor for dependence: risk of tolerance and withdrawal with prolonged use. Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. Store at ambient temperature: keep in the original pack, protect from moisture and light.

Zopiclone may interact with other central nervous system depressants and drugs affecting its metabolism.

Major Interactions (Avoid): - Alcohol: additive CNS depression leading to excessive sedation. - Opioids: increased risk of respiratory depression and profound sedation. - Other CNS depressants (e.g., benzodiazepines, antihistamines): enhanced sedative effects.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise plasma concentrations of Zopiclone. - CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce therapeutic effectiveness.